Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Cash from Discontinued Operations (2023 - 2024)

Mimedx's Cash from Discontinued Operations history spans 2 years, with the latest figure at 1000.0 for Q4 2024.

  • For Q4 2024, Cash from Discontinued Operations fell 99.9% year-over-year to 1000.0; the TTM value through Sep 2025 reached 1000.0, down 98.21%, while the annual FY2024 figure was 930000.0, 88.61% up from the prior year.
  • Cash from Discontinued Operations for Q4 2024 was 1000.0 at Mimedx, up from 1000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 987000.0 in Q4 2023 and bottomed at 4648000.0 in Q1 2023.